TickerFacts.

20/20 Biolabs, Inc. (AIDX): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$19.2K
As of 2025-12-31
$1.62M
As of 2026-06-30
$1.51M2024-12-31: $1.51M2025-12-31: -$19.2K-$19.2K
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$19.2Kn/m2026-03-31, Balance as of period end
2024-12-31$1.51Mn/a2026-03-31, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
20/20 Biolabs, Inc. (AIDX)2025-12-31-$19.2Kn/m
NeoGenomics Inc (NEO)2025-12-31$836.56M-7.3%
UL Solutions Inc. (ULS)2025-12-31$1.29B+39.0%
Hypha Labs, Inc. (FUNI)2025-09-30-$2.44Mn/m

Compare AIDX, NEO, ULS, FUNI side by side · Screen every company in Services-Testing Laboratories ↗